BACE1 and Alzheimer disease: It can thus be envisioned that blocking lncRNA BACE1-AS could be developed as a therapeutic intervention aimed at preventing or mitigating AD-like neuropathology in both HIV-infected individuals, as well as opioid addicts [70].